Jang, Sooyong

Email Address
Research Projects
Organizational Units
Research Interests

Search Results

Now showing 1 - 3 of 3
  • Publication
    Improving Classifier Confidence using Lossy Label-Invariant Transformations
    (2021-04-01) Jang, Sooyong; Lee, Insup; Weimer, James
    Providing reliable model uncertainty estimates is imperative to enabling robust decision making by autonomous agents and humans alike. While recently there have been significant advances in confidence calibration for trained models, examples with poor calibration persist in most calibrated models. Consequently, multiple techniques have been proposed that leverage label-invariant transformations of the input (i.e., an input manifold) to improve worst-case confidence calibration. However, manifold-based confidence calibration techniques generally do not scale and/or require expensive retraining when applied to models with large input spaces (e.g., ImageNet). In this paper, we present the recursive lossy label-invariant calibration (ReCal) technique that leverages label-invariant transformations of the input that induce a loss of discriminatory information to recursively group (and calibrate) inputs – without requiring model retraining. We show that ReCal outperforms other calibration methods on multiple datasets, especially, on large-scale datasets such as ImageNet.
  • Publication
    Reducing Pulse Oximetry False Alarms Without Missing Life-Threatening Events
    (2018-09-01) Nguyen, Hung; Jang, Sooyong; Ivanov, Radoslav; Bonafide, Christopher P.; Weimer, James; Lee, Insup
    Alarm fatigue has been increasingly recognized as one of the most significant problems in the hospital environment. One of the major causes is the excessive number of false physiologic monitor alarms. An underlying problem is the inefficient traditional threshold alarm system for physiologic parameters such as low blood oxygen saturation (SpO2). In this paper, we propose a robust classification procedure based on the AdaBoost algorithm with reject option that can identify and silence false SpO2 alarms, while ensuring zero misclassified clinically significant alarms. Alarms and vital signs related to SpO2 such as heart rate and pulse rate, within monitoring interval are extracted into different numerical features for the classifier. We propose a variant of AdaBoost with reject option by allowing a third decision (i.e., reject) expressing doubt. Weighted outputs of each weak classifier are input to a softmax function optimizing to satisfy a desired false negative rate upper bound while minimizing false positive rate and indecision rate. We evaluate the proposed classifier using a dataset collected from 100 hospitalized children at Children's Hospital of Philadelphia and show that the classifier can silence 23.12% of false SpO2 alarms without missing any clinically significant alarms.
  • Publication
    Characterizing Glycemic Control and Sleep in Adults with Long-Standing Type 1 Diabetes and Hypoglycemia Unawareness Initiating Hybrid Closed Loop Insulin Delivery
    (2021-02-01) Kohl Malone, Susan; Peleckis, Amy J.; Jang, Sooyong; Grunin, Laura; Weimer, James; Yu, Gary; Lee, Insup; Rickels, Michael R.; Goel, Namni
    Nocturnal hypoglycemia is life threatening for individuals with type 1 diabetes (T1D) due to loss of hypoglycemia symptom recognition (hypoglycemia unawareness) and impaired glucose counter regulation. These individuals also show disturbed sleep, which may result from glycemic dysregulation. Whether use of a hybrid closed loop (HCL) insulin delivery system with integrated continuous glucose monitoring (CGM) designed for improving glycemic control, relates to better sleep across time in this population remains unknown. The purpose of this study was to describe long-term changes in glycemic control and objective sleep after initiating hybrid closed loop (HCL) insulin delivery in adults with type 1 diabetes and hypoglycemia unawareness. To accomplish this, six adults (median age = 58 y) participated in an 18-month ongoing trial assessing HCL effectiveness. Glycemic control and sleep were measured using continuous glucose monitoring and wrist accelerometers every 3 months. Paired sample t-tests and Cohen’s d effect sizes modeled glycemic and sleep changes and the magnitude of these changes from baseline to 9 months. Reduced hypoglycemia (d = 0:47‐0:79), reduced basal insulin requirements (d = 0:48), and a smaller glucose coefficient of variation (d = 0:47) occurred with medium-large effect sizes from baseline to 9 months. Hypoglycemia awareness improved from baseline to 6 months with medium-large effect sizes (Clarke score (d = 0:60), lability index (d = 0:50), HYPO score (d = 1:06)). Shorter sleep onset latency (d = 1:53; p < 0:01), shorter sleep duration (d = 0:79), fewer total activity counts (d = 1:32), shorter average awakening length (d = 0:46), and delays in sleep onset (d = 1:06) and sleep midpoint (d = 0:72) occurred with medium-large effect sizes from baseline to 9 months. HCL led to clinically significant reductions in hypoglycemia and improved hypoglycemia awareness. Sleep showed a delayed onset, reduced awakening length and onset latency, and maintenance of high sleep efficiency after initiating HCL. Our findings add to the limited evidence on the relationships between diabetes therapeutic technologies and sleep health. This trial is registered with ClinicalTrials.gov (NCT03215914).